None listed
Conditions
Brief summary
The objective of this study was to determine if either metformin monotherapy or metformin in combination with insulin is equally effective as insulin monotherapy at glycaemic control in diabetes mellitus in pregnancy among Ghanaians
Interventions
Arm 1: metformin only; starting dose 500mg taken orally twice daily and increased gradually every 2 weeks to a maximum dose of 2500mg or till optimum glycaemic control is attained. Treatment begins from enrolment till delivery. Arm 2: insulin only; starting total daily dose of insulin is 0.3-1.0 i.u/kg body weight depending on glycaemic profile at diagnosis. This is titrated up to achieve optimum glycaemic control. Total daily dose of premixed insulin is divided into 2: 2/3 administered 30 min before breakfast and 1/3 administered 30 minutes before supper. insulin is administered subcutaneously in the deltoid region. Insulin is administered from enrolment till delivery. Arm 3: metformin +insulin for failures on arm 1 Failures on arm 1 means worsening glycaemic profile on OGTT i.e. fasting blood glucose greater 7.0 mmol/l or 2-hour post glucose greater 11.0 mmol/l after maximum dose adjustment. Dose and duration of metformin and insulin in this arm is the same as their respective doses and durations in arms 1 and 2. Titration to higher doses is more aggressives to ensure strict control of glycaemic profile. Adherence is monitored tablet and drug return on review visit
Sponsors
Study design
Eligibility
Inclusion criteria
Pregnant with single fetus at gestational age of 20 to 30 weeks and have been diagnosed with Type 2 DM or Gestational Diabetes
Exclusion criteria
patients with pre-gestational diabetes mellitus who require insulin to achieve glycaemic control and patients with contra-indications to metformin therapy